No direct exp here, but lots of exp with anti-D’s, and lots of pharmacological grasp of how they work. Brintellix’s mechanism of action on the serotonin system is much more direct than is the m/a of the SSRIs (like Prozac, etc.) and SNRI’s (like Effexor).
The m/a here is closer to – though not exactly like – the old tricyclic anti-Ds (like Elavil). That suggests that the side-effects may be more like those of the tricyclics, as well. Following are the sfx for Elavil:
Common (≥1% frequency) side effects include dizziness, headache, weight gain, side effects common to anticholinergics, but more such effects than other TCAs, cognitive effects such as delirium and confusion, mood disturbances such as anxiety and agitation, cardiovascular side effects such as orthostatic hypotension and sinus tachycardia, sexual side effects such as loss of libido and impotence, and sleep disturbances such as drowsiness and insomnia.[1][2][3][4][13][14]
Thus I’d keep my eyes, ears and interoceptors peeled for such stuff while in the trial.
The listed sfx of Brintellix at this time include… nausea, diarrhea, xerostomia, constipation, vomiting, flatulence, dizziness, and sexual dysfunction.[2] Vortioxetine used alone in high dose or in combination with other medications, such as other antidepressants, can produce a potentially life-threatening drug reaction known as serotonin syndrome.[7][9][10] Incidence of sexual dysfunction is reportedly higher in patients taking vortioxetine than in patients taking placebos,[2] but lower than in patients taking venlafaxine.
But one has to keep in mind that the sfx reports that emerge from trials or from brief use outside the US (where approval is far more liberal) are very often “conservative” (to be euphemistic) vs. what pops up after ten of fifteen years of follow-on research in the US.